Description

BSE announces listing of new Commercial Papers worth Rs. 700 crores issued by Reliance Industries Limited on private placement basis, with redemption dates in December 2025.

Summary

BSE has listed new Commercial Papers (CPs) issued by Reliance Industries Limited totaling Rs. 700 crores across two tranches. The securities were issued on private placement basis with face value of Rs. 5 lakhs each and will be traded in dematerialized form on the BSE Debt segment. Both tranches carry CARE A1+ and CRISIL A1+ credit ratings and will mature in December 2025.

Key Points

  • Total issuance: Rs. 700 crores (Rs. 250 crores + Rs. 450 crores)
  • Tranche 1: 5,000 CPs of Rs. 5 lakhs each (Scrip Code: 730583, ISIN: INE002A14LO9)
  • Tranche 2: 9,000 CPs of Rs. 5 lakhs each (Scrip Code: 730566, ISIN: INE002A14LN1)
  • Issue price: Rs. 496,708 (Tranche 1) and Rs. 497,107 (Tranche 2)
  • Credit Rating: CARE A1+ and CRISIL A1+ for both tranches
  • Issuing and Paying Agent: ICICI Bank Limited
  • Trading to be conducted only in dematerialized form
  • Market lot: 1 unit, Tick size: 1 paise

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

  • Trading members must note that securities will be traded only in dematerialized form
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
  • Trading members requiring clarification should contact BSE debt department

Important Dates

  • Allotment Date: November 18, 2025 (both tranches)
  • Listing Date: November 18, 2025 (effective from today)
  • Redemption Date (Tranche 1): December 29, 2025
  • Redemption Date (Tranche 2): December 24, 2025

Impact Assessment

Minimal market impact as this is a routine listing of short-term debt instruments by a large, highly-rated corporate issuer. The commercial papers provide short-term funding options for Reliance Industries and investment opportunities for debt market participants. The high credit ratings (A1+ from both CARE and CRISIL) indicate low credit risk. This listing only affects participants in the BSE debt segment and does not impact equity markets or broader trading operations.

Impact Justification

Routine commercial paper listing by large corporate issuer. No regulatory changes or market-wide impact. Affects only debt segment participants.